封面
市場調查報告書
商品編碼
1609730

2024-2032 年日本放射治療市場報告(按類型、應用、最終用戶和地區)

Japan Radiotherapy Market Report by Type, Application, End User, and Region 2024-2032

出版日期: | 出版商: IMARC | 英文 122 Pages | 商品交期: 5-7個工作天內

價格
簡介目錄

2023年日本放射治療IMARC Group規模達4.212億美元。醫療保健支出能力的膨脹,以及對緩解晚期癌症症狀的有效治療方法的需求不斷成長,是市場成長的主要動力。

放射治療,也稱為放射治療,其目的是延緩癌細胞的增殖並縮小腫瘤的大小。這種治療方式透過利用高能粒子或波(包括 X光、伽馬射線、電子束或質子)來破壞癌細胞內的遺傳物質。在許多情況下,它與其他癌症療法(例如手術、化療和免疫療法)結合使用,以增強其療效。據此,對患者進行放射治療的決定取決於特定癌症類型、腫瘤的大小和位置、患者的病史、年齡和整體健康狀況等因素。因此,它被用於日本各地的醫院。

日本放射治療市場趨勢:

由於不健康的飲食習慣、體力活動不足、空氣污染水平上升以及菸酒消費量的增加,癌症發病率不斷上升,這是推動日本市場成長的主要因素。此外,隨著年齡的成長,癌症發生的風險顯著上升,因為細胞修復機制在老年人中變得不太有效。因此,日本老年人口的增加是市場擴張的另一個重要催化劑。此外,具有成本效益、方便用戶使用的放射治療產品的進步進一步促進了市場成長。此外,3D(3D) 適形、強度調節和影像引導方法等現代放射治療技術可為腫瘤提供更高的放射劑量,同時最大限度地減少健康組織的暴露,增強對關鍵器官的保護,並為患者提供無痛治療。這些技術在治療慢性病的各種應用和醫療保健環境中越來越受到關注,從而推動了全球對放射治療的需求。此外,由於日本已開發經濟體和新興經濟體的醫療保健支出不斷增加,該市場可望成長。所有這些因素預計將在未來幾年推動區域市場的發展。

日本放射治療市場細分:

類型見解:

  • 外束放射治療
  • 調強放射治療 (IMRT)
  • 影像導引放射治療 (IGRT)
  • 斷層放射治療
  • 立體定位放射外科
  • 立體定位放射治療
  • 質子治療
  • 3D 適形放射治療 (3D CRT)
  • 容積調製電弧療法 (VMAT)
  • 內部放射治療/近距離放射治療
  • 全身放射治療

應用見解:

  • 皮膚癌和唇癌
  • 頭頸癌
  • 乳癌
  • 攝護腺癌
  • 子宮頸癌
  • 肺癌
  • 其他

最終使用者見解:

  • 醫院
  • 癌症研究機構
  • 門診及放射治療中心

競爭格局:

市場研究報告也對競爭格局進行了全面分析。報告涵蓋了市場結構、關鍵參與者定位、最佳制勝策略、競爭儀表板和公司評估象限等競爭分析。此外,也提供了所有主要公司的詳細資料。一些主要參與者包括:

  • 醫科達 (Elekta)
  • 日立製作所
  • 大阪重粒子線治療中心
  • 住友重工業株式會社
  • 東芝公司

本報告回答的關鍵問題:

  • 日本放射治療市場迄今為止的表現如何以及未來幾年的表現如何?
  • COVID-19 對日本放射治療市場有何影響?
  • 日本放射治療市場按類型分類是怎樣的?
  • 日本放射治療市場的應用如何?
  • 日本放射治療市場的最終用戶細分如何?
  • 日本放射治療市場價值鏈的各個階段是什麼?
  • 日本放射治療的關鍵促進因素和挑戰是什麼?
  • 日本放射治療市場的結構如何?
  • 日本放射治療市場的競爭程度如何?

本報告回答的關鍵問題:

  • 日本放射治療市場迄今為止的表現如何以及未來幾年的表現如何?
  • COVID-19 對日本放射治療市場有何影響?
  • 日本放射治療市場按類型分類是怎樣的?
  • 日本放射治療市場的應用如何?
  • 日本放射治療市場的最終用戶細分如何?
  • 日本放射治療市場價值鏈的各個階段是什麼?
  • 日本放射治療的關鍵促進因素和挑戰是什麼?
  • 日本放射治療市場的結構如何?
  • 日本放射治療市場的競爭程度如何?

目錄

第1章:前言

第 2 章:範圍與方法

  • 研究目的
  • 利害關係人
  • 數據來源
    • 主要來源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章:執行摘要

第 4 章:日本放射治療市場 - 簡介

  • 概述
  • 市場動態
  • 產業動態
  • 競爭情報

第 5 章:日本放射治療市場格局

  • 歷史與當前市場趨勢(2018-2023)
  • 市場預測(2024-2032)

第 6 章:日本放射治療市場 - 細分:按類型

  • 外束放射治療
    • 概述
    • 歷史與當前市場趨勢(2018-2023)
    • 市場區隔
      • 調強放射治療 (IMRT)
      • 影像導引放射治療 (IGRT)
      • 斷層放射治療
      • 立體定位放射外科
      • 立體定位放射治療
      • 質子治療
      • 3D 適形放射治療 (3D CRT)
      • 容積調製電弧療法 (VMAT)
    • 市場預測(2024-2032)
  • 內部放射治療/近距離放射治療
    • 概述
    • 歷史與當前市場趨勢(2018-2023)
    • 市場預測(2024-2032)
  • 全身放射治療
    • 概述
    • 歷史與當前市場趨勢(2018-2023)
    • 市場預測(2024-2032)

第 7 章:日本放射治療市場 - 細分:按應用分類

  • 皮膚癌和唇癌
    • 概述
    • 歷史與當前市場趨勢(2018-2023)
    • 市場預測(2024-2032)
  • 頭頸癌
    • 概述
    • 歷史與當前市場趨勢(2018-2023)
    • 市場預測(2024-2032)
  • 乳癌
    • 概述
    • 歷史與當前市場趨勢(2018-2023)
    • 市場預測(2024-2032)
  • 攝護腺癌
    • 概述
    • 歷史與當前市場趨勢(2018-2023)
    • 市場預測(2024-2032)
  • 子宮頸癌
    • 概述
    • 歷史與當前市場趨勢(2018-2023)
    • 市場預測(2024-2032)
  • 肺癌
    • 概述
    • 歷史與當前市場趨勢(2018-2023)
    • 市場預測(2024-2032)
  • 其他
    • 歷史與當前市場趨勢(2018-2023)
    • 市場預測(2024-2032)

第 8 章:日本放射治療市場 - 細分:按最終用戶分類

  • 醫院
    • 概述
    • 歷史與當前市場趨勢(2018-2023)
    • 市場預測(2024-2032)
  • 癌症研究機構
    • 概述
    • 歷史與當前市場趨勢(2018-2023)
    • 市場預測(2024-2032)
  • 門診及放射治療中心
    • 概述
    • 歷史與當前市場趨勢(2018-2023)
    • 市場預測(2024-2032)

第 9 章:日本放射治療市場 - 競爭格局

  • 概述
  • 市場結構
  • 市場參與者定位
  • 最佳制勝策略
  • 競爭儀表板
  • 公司評估象限

第 10 章:關鍵參與者簡介

  • Elekta K.K. (Elekta)
    • Business Overview
    • Services Offered
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Hitachi Ltd.
    • Business Overview
    • Services Offered
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Osaka Heavy Ion Therapy Center
    • Business Overview
    • Services Offered
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Sumitomo Heavy Industries Ltd.
    • Business Overview
    • Services Offered
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Toshiba Corporation
    • Business Overview
    • Services Offered
    • Business Strategies
    • SWOT Analysis
    • Major News and Events

請注意,這只是關鍵參與者的部分列表,報告中提供了完整列表。

第 11 章:日本放射治療市場 - 產業分析

  • 促進因素、限制因素和機會
    • 概述
    • 促進要素
    • 限制
    • 機會
  • 波特五力分析
    • 概述
    • 買家的議價能力
    • 供應商的議價能力
    • 競爭程度
    • 新進入者的威脅
    • 替代品的威脅
  • 價值鏈分析

第 12 章:附錄

簡介目錄
Product Code: SR112024A18341

Japan radiotherapy market size reached US$ 421.2 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 716.1 Million by 2032, exhibiting a growth rate (CAGR) of 5.5% during 2024-2032. The inflating healthcare expenditure capacities, along with the growing need for effective treatment methods that relieve symptoms of advanced cancers, are primarily driving the market growth.

Radiotherapy, alternatively referred to as radiation therapy, serves the purpose of retarding the proliferation of cancer cells and reducing the size of tumors. This treatment modality disrupts the genetic material within cancer cells through the utilization of high-energy particles or waves, encompassing options like x-rays, gamma rays, electron beams, or protons. In many cases, it is employed in conjunction with other cancer therapies such as surgery, chemotherapy, and immunotherapy to enhance their efficacy. In line with this, the decision to administer radiotherapy to patients hinges on factors such as the specific cancer type, the tumor's dimensions and location, the patient's medical history, age, and overall health conditions. Consequently, it is used in hospitals across Japan.

Japan Radiotherapy Market Trends:

The increasing incidence of cancer due to unhealthy dietary habits, insufficient physical activity, rising air pollution levels, and the growing consumption of alcohol and tobacco constitutes a major factor driving market growth in Japan. Furthermore, the risk of cancer development significantly escalates with age, as cellular repair mechanisms become less effective in older individuals. Consequently, the increasing elderly population in Japan is acting as another substantial catalyst for market expansion. Additionally, the advancement of cost-effective, user-friendly radiotherapy products is further augmenting market growth. Furthermore, modern radiotherapy techniques like three-dimensional (3D) conformal, intensity-modulated, and image-guided approaches deliver a higher radiation dose to tumors while minimizing exposure to healthy tissues, enhancing the protection of critical organs, and providing patients with a painless experience, which is acting as another significant growth-inducing factor. These techniques are gaining traction across various applications and healthcare settings for the treatment of chronic diseases, consequently driving global demand for radiotherapy. Moreover, the market is poised for growth due to the escalating healthcare expenditure in both developed and emerging economies within Japan. All these factors are expected to propel the regional market in the coming years.

Japan Radiotherapy Market Segmentation:

Type Insights:

  • External Beam Radiation Therapy
  • Intensity-Modulated Radiation Therapy (IMRT)
  • Image-Guided Radiation Therapy (IGRT)
  • Tomotherapy
  • Stereotactic Radiosurgery
  • Stereotactic Body Radiation Therapy
  • Proton Therapy
  • 3D Conformal Radiotherapy (3D CRT)
  • Volumetric Modulated Arc Therapy (VMAT)
  • Internal Radiation Therapy/Brachytherapy
  • Systemic Radiation Therapy

Application Insights:

  • Skin and Lip Cancer
  • Head and Neck Cancer
  • Breast Cancer
  • Prostate Cancer
  • Cervical Cancer
  • Lung Cancer
  • Others

End User Insights:

  • Hospitals
  • Cancer Research Institutes
  • Ambulatory and Radiotherapy Centers

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the key players include:

  • Elekta K.K. (Elekta)
  • Hitachi Ltd.
  • Osaka Heavy Ion Therapy Center
  • Sumitomo Heavy Industries Ltd.
  • Toshiba Corporation

Key Questions Answered in This Report:

  • How has the Japan radiotherapy market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan radiotherapy market?
  • What is the breakup of the Japan radiotherapy market on the basis of type?
  • What is the breakup of the Japan radiotherapy market on the basis of application?
  • What is the breakup of the Japan radiotherapy market on the basis of end user?
  • What are the various stages in the value chain of the Japan radiotherapy market?
  • What are the key driving factors and challenges in the Japan radiotherapy?
  • What is the structure of the Japan radiotherapy market and who are the key players?
  • What is the degree of competition in the Japan radiotherapy market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Radiotherapy Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Radiotherapy Market Landscape

  • 5.1 Historical and Current Market Trends (2018-2023)
  • 5.2 Market Forecast (2024-2032)

6 Japan Radiotherapy Market - Breakup by Type

  • 6.1 External Beam Radiation Therapy
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2018-2023)
    • 6.1.3 Market Segmentation
      • 6.1.3.1 Intensity-Modulated Radiation Therapy (IMRT)
      • 6.1.3.2 Image-Guided Radiation Therapy (IGRT)
      • 6.1.3.3 Tomotherapy
      • 6.1.3.4 Stereotactic Radiosurgery
      • 6.1.3.5 Stereotactic Body Radiation Therapy
      • 6.1.3.6 Proton Therapy
      • 6.1.3.7 3D Conformal Radiotherapy (3D CRT)
      • 6.1.3.8 Volumetric Modulated Arc Therapy (VMAT)
    • 6.1.4 Market Forecast (2024-2032)
  • 6.2 Internal Radiation Therapy/Brachytherapy
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2018-2023)
    • 6.2.3 Market Forecast (2024-2032)
  • 6.3 Systemic Radiation Therapy
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2018-2023)
    • 6.3.3 Market Forecast (2024-2032)

7 Japan Radiotherapy Market - Breakup by Application

  • 7.1 Skin and Lip Cancer
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2018-2023)
    • 7.1.3 Market Forecast (2024-2032)
  • 7.2 Head and Neck Cancer
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2018-2023)
    • 7.2.3 Market Forecast (2024-2032)
  • 7.3 Breast Cancer
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2018-2023)
    • 7.3.3 Market Forecast (2024-2032)
  • 7.4 Prostate Cancer
    • 7.4.1 Overview
    • 7.4.2 Historical and Current Market Trends (2018-2023)
    • 7.4.3 Market Forecast (2024-2032)
  • 7.5 Cervical Cancer
    • 7.5.1 Overview
    • 7.5.2 Historical and Current Market Trends (2018-2023)
    • 7.5.3 Market Forecast (2024-2032)
  • 7.6 Lung Cancer
    • 7.6.1 Overview
    • 7.6.2 Historical and Current Market Trends (2018-2023)
    • 7.6.3 Market Forecast (2024-2032)
  • 7.7 Others
    • 7.7.1 Historical and Current Market Trends (2018-2023)
    • 7.7.2 Market Forecast (2024-2032)

8 Japan Radiotherapy Market - Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2018-2023)
    • 8.1.3 Market Forecast (2024-2032)
  • 8.2 Cancer Research Institutes
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2018-2023)
    • 8.2.3 Market Forecast (2024-2032)
  • 8.3 Ambulatory and Radiotherapy Centers
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2018-2023)
    • 8.3.3 Market Forecast (2024-2032)

9 Japan Radiotherapy Market - Competitive Landscape

  • 9.1 Overview
  • 9.2 Market Structure
  • 9.3 Market Player Positioning
  • 9.4 Top Winning Strategies
  • 9.5 Competitive Dashboard
  • 9.6 Company Evaluation Quadrant

10 Profiles of Key Players

  • 10.1 Elekta K.K. (Elekta)
    • 10.1.1 Business Overview
    • 10.1.2 Services Offered
    • 10.1.3 Business Strategies
    • 10.1.4 SWOT Analysis
    • 10.1.5 Major News and Events
  • 10.2 Hitachi Ltd.
    • 10.2.1 Business Overview
    • 10.2.2 Services Offered
    • 10.2.3 Business Strategies
    • 10.2.4 SWOT Analysis
    • 10.2.5 Major News and Events
  • 10.3 Osaka Heavy Ion Therapy Center
    • 10.3.1 Business Overview
    • 10.3.2 Services Offered
    • 10.3.3 Business Strategies
    • 10.3.4 SWOT Analysis
    • 10.3.5 Major News and Events
  • 10.4 Sumitomo Heavy Industries Ltd.
    • 10.4.1 Business Overview
    • 10.4.2 Services Offered
    • 10.4.3 Business Strategies
    • 10.4.4 SWOT Analysis
    • 10.4.5 Major News and Events
  • 10.5 Toshiba Corporation
    • 10.5.1 Business Overview
    • 10.5.2 Services Offered
    • 10.5.3 Business Strategies
    • 10.5.4 SWOT Analysis
    • 10.5.5 Major News and Events

Please note that this is only a partial list of the key players, and the complete list is provided in the report.

11 Japan Radiotherapy Market - Industry Analysis

  • 11.1 Drivers, Restraints, and Opportunities
    • 11.1.1 Overview
    • 11.1.2 Drivers
    • 11.1.3 Restraints
    • 11.1.4 Opportunities
  • 11.2 Porters Five Forces Analysis
    • 11.2.1 Overview
    • 11.2.2 Bargaining Power of Buyers
    • 11.2.3 Bargaining Power of Suppliers
    • 11.2.4 Degree of Competition
    • 11.2.5 Threat of New Entrants
    • 11.2.6 Threat of Substitutes
  • 11.3 Value Chain Analysis

12 Appendix